The website is the electronic means of communication of the Drug Therapeutic Committee and the Public Healthcare
Services Committee Administration of Stockholm County Council, Sweden.
Contents and functions of the website should contribute to evidence-based and cost-effective drug treatment. Our aim is to become the main website of drug information for healthcare professionals in the Stockholm area.
The information on the website has been developed in collaboration with clinical pharmacologists and other experts in specific therapeutic areas.
Contents in brief
• Therapeutic guidelines
• Kloka Listan (Wise Drug Formulary; recommended drugs)
• Evaluation of new drugs
• Drugs and birth defects
• Drugs and breastfeeding
• Summaries from seminars
• Drug statistics.
The editorial board systematically follows developments in the field of drug treatment and publishes brief medical as well as general news articles related to drugs. An important criteria for news selection is that it should be considered to be or to become relevant in patient care.
The website also offers summaries of regional and national symposia and educational activities.
An important part of Janusinfo consists of evidence-based guidelines produced by Drug Expert Panels. The panels also produce the Kloka Listan (Wise Drug Formulary), which contains those drugs that have been recommended and Informatics.
Drug statistics offer sales returns and sales statistics of drugs in Stockholm County with analysis and comments.
For more information
Public Healthcare Services Committee Administration
Magnus Ladulåsgatan 63A
SE-118 27 Stockholm
Phone: +46 8 737 40 40
Fax: +46 8 737 40 12
1. Gustafsson LL, Wettermark B, Godman B, Andersén-Karlsson E, Bergman U, Hasselström J et al. The 'Wise List' – A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm. Basic & Clinical Pharmacology & Toxicology 2011 Apr;108(4):224-33. PubMed
2. Editorial (ledare). The 'wise list'- a comprehensive model for drug and therapeutics committees to achieve adherence to recommendations for essential drugs among prescribers? Basic & Clinical Pharmacology & Toxicology. 2011 Apr;108(4):221-3. PubMed